Bioreliance Corp Sample Contracts

1 EXHIBIT 10.16 LEASE AGREEMENT
Lease Agreement • March 31st, 1998 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
AutoNDA by SimpleDocs
LOAN AGREEMENT
Loan Agreement • August 13th, 1999 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
RECITALS:
Lease Agreement • March 31st, 1998 • Bioreliance Corp • Services-commercial physical & biological research
2. Loan Agreement applies to the new debt as evidenced by Note dated June 27, 1996 for $1,800,000.00.
Loan Agreement • July 1st, 1997 • Bioreliance Corp • Services-commercial physical & biological research
LEASE BETWEEN
Bioreliance Corp • May 15th, 1998 • Services-commercial physical & biological research • Maryland
EMPLOYMENT AGREEMENT BETWEEN BIORELIANCE CORPORATION AND JOHN E. McENTIRE, Ph.D.
Employment Agreement • March 30th, 2000 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
2 3 (e) "Commitment" shall mean the commitment letter from the Lender to the Borrower and the Guarantors dated February 19, 1998.
Loan Agreement • May 15th, 1998 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
PROFESSIONAL SERVICES AGREEMENT BETWEEN BIORELIANCE CORPORATION AND JEFFREY M. OSTROVE, PH.D.
Professional Services Agreement • March 31st, 1998 • Bioreliance Corp • Services-commercial physical & biological research
1 EXHIBIT 10.36 NOTE MODIFICATION AGREEMENT BY AND BETWEEN NATIONSBANK, N.A. ("BANK"/"LENDER") AND
Note Modification Agreement • August 13th, 1999 • Bioreliance Corp • Services-commercial physical & biological research
EMPLOYMENT AGREEMENT
Employment Agreement • May 15th, 2003 • Bioreliance Corp • Services-commercial physical & biological research • Maryland

THIS AGREEMENT is effective the 8th day of January, 2003 by and between BioReliance Corporation, a Delaware corporation with principal offices located at 14920 Broschart Road, Rockville, Maryland 20850, and all of its subsidiary companies and its successors or assigns (the “Corporation”) and David E. Jackson (the “Executive”).

RECITALS
Assignment and Security Agreement • May 15th, 1998 • Bioreliance Corp • Services-commercial physical & biological research
1 2 EXHIBIT 10.39
Trust Note Modification Agreement • March 30th, 2000 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
RECITALS
Replacement Loan Agreement • March 30th, 2000 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
AutoNDA by SimpleDocs
NOTE MODIFICATION AND EXTENSION AGREEMENT
Note Modification and Extension Agreement • July 1st, 1997 • Bioreliance Corp • Services-commercial physical & biological research
EMPLOYMENT AGREEMENT
Employment Agreement • May 15th, 2002 • Bioreliance Corp • Services-commercial physical & biological research • Maryland

THIS AGREEMENT is effective the 31st day of December, 2001 by and between BioReliance Corporation, a Delaware corporation with principal offices located at 14920 Broschart Road, Rockville, Maryland 20850, and all of its subsidiary companies and its successors or assigns (the “Corporation”) and Ronald R. Baker (the “Executive”).

EMPLOYEE CONFIDENTIALITY, TRADE SECRETS AND NONCOMPETITION AGREEMENT
Bioreliance Corp • November 14th, 2002 • Services-commercial physical & biological research • Maryland
Exhibit B-1 FORM OF REVOLVING NOTE
Credit Agreement • October 8th, 2003 • Bioreliance Corp • Services-commercial physical & biological research

FOR VALUE RECEIVED, the undersigned (the “Borrower”), hereby promises to pay to ______or its registered assigns (the “Lender”), in accordance with the provisions of the Credit Agreement (as hereinafter defined), the principal amount of each Revolving Loan from time to time made by the Lender to the Borrower under that certain Credit Agreement (as amended, modified, supplemented and extended from time to time, the “Credit Agreement”) dated as of August 12, 2003 among BioReliance Corporation, a Delaware corporation (“BioReliance”), BioReliance (Glasgow) Ltd., a Scottish private limited company (the “Foreign Borrower”; together with BioReliance, the “Borrowers”), the Guarantors identified therein, the Lenders identified therein, and Bank of America, N.A., as Administrative Agent, Security Trustee and L/C Issuer. Capitalized terms used but not otherwise defined herein have the meanings provided in the Credit Agreement.

BETWEEN
Lease-Purchase Agreement • May 15th, 1998 • Bioreliance Corp • Services-commercial physical & biological research • Maryland
VOTING AND TENDER AGREEMENT by and among INVITROGEN CORPORATION and SIDNEY R. KNAFEL, DOUGLAS R. KNAFEL 1978 TRUST, ANDREW G. KNAFEL 1978 TRUST, DOUGLAS R. AND ANDREW G. KNAFEL 1976 TRUST, DOUGLAS R. KNAFEL 1983 TRUST, ANDREW G. KNAFEL, KNAFEL FAMILY...
Voting and Tender Agreement • January 5th, 2004 • Bioreliance Corp • Services-commercial physical & biological research • Delaware

This Voting and Tender Agreement (this “Agreement”) is entered into as of December 24, 2003, by and among Invitrogen Corporation, a Delaware corporation (“Parent”), and Sidney R. Knafel, Douglas R. Knafel 1978 Trust, Andrew G. Knafel 1978 Trust, Douglas R. and Andrew G. Knafel 1976 Trust, Douglas R. Knafel 1983 Trust, Andrew G. Knafel, Knafel Family Foundation, Estate of Susan R. Knafel and ICI Communications, Inc. (collectively, the “Stockholders”).

FOURTH MODIFICATION AGREEMENT — LEASEHOLD DEED OF TRUST AND SECURITY AGREEMENT
Fourth Modification Agreement • April 1st, 2002 • Bioreliance Corp • Services-commercial physical & biological research • Maryland

THIS FOURTH MODIFICATION AGREEMENT — LEASEHOLD DEED OF TRUST AND SECURITY AGREEMENT (this “Amendment”) is made as of the 1st day of October, 2001 by and among BIORELIANCE CORPORATION, a corporation organized and in good standing under the laws of State of Delaware, successor in interest to and formerly known of record as MICROBIOLOGICAL ASSOCIATES, INC., (the “Grantor”), ELIZABETH F. SHORE, as trustee (the “Trustee”) and BANK OF AMERICA, N.A., successor to NATIONSBANK, N.A., a national banking association successor-in-interest to MARYLAND NATIONAL BANK, a national banking association (the “Beneficiary”).

DATE PARTIES OPERATIVE PROVISIONS
Bioreliance Corp • January 8th, 2004 • Services-commercial physical & biological research
FOURTH AMENDMENT TO AMENDED AND RESTATED REPLACEMENT LOAN AGREEMENT
Replacement Loan Agreement • April 1st, 2002 • Bioreliance Corp • Services-commercial physical & biological research • Maryland

THIS FOURTH AMENDMENT TO AMENDED AND RESTATED REPLACEMENT LOAN AGREEMENT (the “Agreement”) is made this 1st day of October, 2001 by and among BIORELIANCE CORPORATION, a corporation organized and in good standing under the laws of the State of Delaware, successor in interest to Microbiological Associates, Inc. (the “Company”), BIORELIANCE TESTING AND DEVELOPMENT, LLC, a limited liability company organized and in good standing under the laws of the State of Delaware (“BT&D LLC”), BIORELIANCE MANUFACTURING, LLC, a limited liability company organized and in good standing under the laws of the State of Delaware (“BMF LLC”) and BIORELIANCE VIRAL MANUFACTURING, INC. (formerly known as Magenta Viral Production, Inc.), successor in interest to BioReliance Testing and Development, Inc. and BioReliance Manufacturing, Inc., a corporation organized and in good standing under the laws of the State of Delaware (“Viral Manufacturing”; together with the Company, BT&D LLC, and BMF LLC, each a “Borrower”

PLEDGE AGREEMENT
Pledge Agreement • October 8th, 2003 • Bioreliance Corp • Services-commercial physical & biological research • New York

THIS PLEDGE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Pledge Agreement”) dated as of September 22, 2003 is by and among the parties identified as “Pledgors” on the signature pages hereto and such other parties as may become Pledgors hereunder after the date hereof (collectively the “Pledgors”) and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”) for the Secured Parties (defined below).

AMENDMENT NO. 1 & CONSENT
Bioreliance Corp • October 8th, 2003 • Services-commercial physical & biological research • New York

THIS AMENDMENT NO. 1 & CONSENT dated as of September 22, 2003 (this “Amendment”) of the Credit Agreement referenced below is by and among BIORELIANCE CORPORATION, a Delaware corporation (“BioReliance”), BIORELIANCE (GLASGOW) LIMITED, a Scottish private limited company (the “Foreign Borrower”; together with BioReliance, the “Borrowers”), the Guarantors and Lenders party hereto and BANK OF AMERICA, N.A., as Administrative Agent, Security Trustee and L/C Issuer. Capitalized terms used but not otherwise defined herein shall have the meanings provided in the Credit Agreement.

Contract
Bioreliance Corp • November 14th, 2002 • Services-commercial physical & biological research • Maryland
Time is Money Join Law Insider Premium to draft better contracts faster.